Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35084987

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Apr 10
First author
Versteijne E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 May;19(5):285-286. doi: 10.1038/s41571-022-00612-6.
    note
    Source null
    related pmid
    35194164
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 Oct 1;40(28):3346. doi: 10.1200/JCO.22.00432.
    note
    Source null
    related pmid
    35737910
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Oct 1;40(28):3346-3347. doi: 10.1200/JCO.22.00538.
    note
    Source null
    related pmid
    35737924
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2022 Oct 1;40(28):3347-3348. doi: 10.1200/JCO.22.00454.
    note
    Source null
    related pmid
    35737925
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):545-552. doi: 10.1016/j.ijrobp.2022.10.022.
    note
    Source null
    related pmid
    36725162
    relationship
    Comment in

Authors and identifiers

  1. name
    Versteijne E
    type
    Author
  2. name
    van Dam JL
    type
    Author
  3. name
    Suker M
    type
    Author
  4. name
    Janssen QP
    type
    Author
  5. name
    Groothuis K
    type
    Author
  6. name
    Akkermans-Vogelaar JM
    type
    Author
  7. name
    Besselink MG
    type
    Author
  8. name
    Bonsing BA
    type
    Author
  9. name
    Buijsen J
    type
    Author
  10. name
    Busch OR
    type
    Author
  11. name
    Creemers GM
    type
    Author
  12. name
    van Dam RM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Versteijne E
    type
    Author
  2. name
    van Dam JL
    type
    Author
  3. name
    Suker M
    type
    Author
  4. name
    Janssen QP
    type
    Author
  5. name
    Groothuis K
    type
    Author
  6. name
    Akkermans-Vogelaar JM
    type
    Author
  7. name
    Besselink MG
    type
    Author
  8. name
    Bonsing BA
    type
    Author
  9. name
    Buijsen J
    type
    Author
  10. name
    Busch OR
    type
    Author
  11. name
    Creemers GM
    type
    Author
  12. name
    van Dam RM
    type
    Author
bibliography ids
  1. nci-bib-6116f3d8e2b4467582fdff49
book metadata
content sha256
0b19842ccd022c190e06615ab41294a7309a63d07827b5dbfe01b2221841250a
document type
citation
dois
  1. 10.1200/JCO.21.02233
electronic publication date
display
2022 Jan 27
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35084987
immutable id
pubmed:35084987@0b19842ccd022c190e06615ab41294a7309a63d07827b5dbfe01b2221841250a
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1220-1230
volume
40
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 May;19(5):285-286. doi: 10.1038/s41571-022-00612-6.
    note
    Source null
    related pmid
    35194164
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 Oct 1;40(28):3346. doi: 10.1200/JCO.22.00432.
    note
    Source null
    related pmid
    35737910
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Oct 1;40(28):3346-3347. doi: 10.1200/JCO.22.00538.
    note
    Source null
    related pmid
    35737924
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2022 Oct 1;40(28):3347-3348. doi: 10.1200/JCO.22.00454.
    note
    Source null
    related pmid
    35737925
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):545-552. doi: 10.1016/j.ijrobp.2022.10.022.
    note
    Source null
    related pmid
    36725162
    relationship
    Comment in
outcomes validated
false
pmid
35084987
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
0e08cd87b06e02bcb1194dbe538e4fdc0603457e557647156577f1a8d2e92b79
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Apr 10
precision
day
year
2022
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35084987/
title
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Preserved source evidence · Not medical advice